PATENT CLAIM ANALYSIS

Application Number: 16005137
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "114000"]

Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.

Claim (Index 4):
The method according to  claim 1 , wherein the S1P receptor modulator is 2-amino-2-[2-(4-octylphenyl) ethyl]propane-1,3-diol in free form or 2-amino-2-[2-(4-octylphenyl) ethyl]propane-1,3-diol hydrochloride.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12655049', '15986992', '15534929', '13149468', '14257342']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7616136826573702
- 35 USC 102 Novelty (BERT): 0.5073206076601153
- Combined Prediction Score: 0.7361843751576447
- Mean Citation Score: 236.143412
- Max Citation Score: 282.18494
- Similarity Product: 240.550405965395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test